Global Cannabis Applications Corp (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF), a leading developer of innovative smartphone applications for the cannabis industry, announces it will launch two medical cannabis applications for the global medical cannabis market.
In early July 2017, GCAC will launch Citizen Green’s CannaMed and CannaLife, two apps built specifically for new and existing global medical cannabis users that will be available in German, English, Italian, French and Spanish across the globe.  Both applications utilize GCAC’s CannaCube Pain To Strain™ user-friendly technology that incorporates a proprietary database of over 10 years of field research that uniquely allows medicinal cannabis users to create individual user profile preferences to address one or multiple conditions for which they seek therapeutic benefits
Built from the original Citizen Green app code base, CannaMed users worldwide can learn more about the medical cannabis products they are using and read other users’ feedback as well as provide their own.
The highly customizable user profile assists CannaMed users in discovering other options that have helped patients with the same condition.  By turning on or off certain product attributes, CannaMed users can view a wide array of product options and reviews to personalize their experience even more.  Where cannabis is legally sold in dispensaries, online or pharmacies, CannaMed displays the best product options on an interactive map.
GCAC’s CannaLife is the first medicinal cannabis-related social media platform of its kind.  Similar to CannaMed, users create a unique user profile using CannaCube, allowing them to create unique profile preferences.  Using the information from these preferences, CannaLife users have access to multiple options based on topics of interest.  Using a dedicated cannabis-specific in-app search engine, CannaLife users can create and post content, join or create related topic-based communities, tag topics across multiple platforms, share information and receive and send alerts.  Both CannaLife and CannaMed are both joined by a single sign on process, similar to leading apps like Facebook and Instagram, allowing user community bases to easily share and grow.
The Company’s business is focused on big data, aggregated through mobile technology that enables patients, doctors, pharmacists, providers and practitioners to more easily identify key strains of cannabis that have the most benefit to target ailments and foster personal well being.  Unique to GCAC is the integration of user-generated data aggregated over 10 years of observational reports for pain relief / benefits, matched to a derived strain of cannabis or plant extract.
States CEO Brad Moore, “Unlike other online marijuana resources  that have been purely recreational, all Citizen Green apps are truly about medical cannabis.  We are using an innovative approach of technology and user rich data to help our app users learn, understand and participate in the growing world of medical cannabis.”
About Global Cannabis Applications Corp.
Global Cannabis Applications Corp. is a global leader in designing, developing, marketing, and acquiring innovative mobile applications.  Used in over 25 countries, GCAC’s apps facilitate the proliferation of digital conversations by like-minded people.  Managed by digital industry experts, GCAC is focused on viral global expansion by providing the best user experience in each target market.  Its leading mobile platforms are Citizen Green, a family of apps dedicated to the digital world of all things cannabis; Foro, a peer-to-peer mobile ecommerce student marketplace; Opinit, an app that enables users to socially share their favourite online sentiment-driven content; and Truth, a one-to-one anonymous messaging app.
For more information about the Company, please visit online at www.cannappscorp.com, or review its profiles on the SEDAR website (www.sedar.com) and on the Canadian Securities Exchange’s website (www.thecse.com).
To schedule an interview, please contact:
Bradley Moore
Chief Executive Officer
Telephone:  514-561-9091
Email: bmoore@cannappscorp.com
For more information, please contact:
Corporate Communications
Telephone: 1.855.269.9554
Email: info@cannappscorp.com
www.cannappscorp.com
Forward-Looking Information
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC.  Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC.  Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct.  Forward-looking statements contained in this press release are made as of the date of this press release.  GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Click here to connect with Global Cannabis Applications Corp (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF)) to receive an Investor Kit.

Source: www.stockhouse.com


 Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/acb .

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less